Drug intelligence / Profile preview

diclofenac diethylamine

Development stage
Phase 3
Lead developer
Zambon
Modality
Small Molecules
Administration
Topical, Transdermal
01

Overview

Z7202 is a topical medicated plaster developed by Zambon S.p.A. containing diclofenac diethylamine (DEA) as its active ingredient. It is formulated as a once-daily adhesive plaster designed for local transdermal delivery of diclofenac, a non-steroidal anti-inflammatory drug (NSAID). Diclofenac works by inhibiting the cyclooxygenase enzymes COX-1 and COX-2, which are responsible for the synthesis of prostaglandins that mediate pain and inflammation. Z7202 is intended for the treatment of acute post-traumatic pain, including pain due to sprains, strains, and contusions. It was evaluated in a Phase 3 randomized clinical trial comparing its efficacy and safety to the twice-daily Flector plaster (which contains diclofenac hydroxyethylpyrrolidine), with Z7202's once-daily dosing regimen representing a potential convenience advantage for patients.

Brand names
Artinil-KArtinil-K GelDifenac GelVoltaren EmulgelVoltaren SchmerzgelVoltarol Emulgel
Other names
diclofenac diethylamine medicated plasterdiclofenac DEA plaster
02

Targets

PGHS-1 (Prostaglandin G/H Synthase 1)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)

Beyond the preview

Go deeper on diclofenac diethylamine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on diclofenac diethylamine.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call